Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 13, pseudogene (RNU2-13P)
- Target
- RNU2-13P
- Molecular classification
- Pseudogene, Small nuclear RNA pseudogene, Non-coding RNA pseudogene
01
Overview
RNA, U2 small nuclear 13, pseudogene (RNU2-13P) is a processed pseudogene of the U2 small nuclear RNA (snRNA) gene family, which is normally involved in pre-mRNA splicing within the spliceosome. Unlike the functional U2 snRNA genes, RNU2-13P does not produce a functional RNA product and is considered an inactive genomic element. Pseudogenes like RNU2-13P arise via duplication or retrotransposition and typically display high sequence similarity to their functional counterparts, but accumulate mutations and truncations rendering them non-functional. There is no evidence for a biological or therapeutic role for this pseudogene. RNU2-13P is a non-functional pseudogene of the U2 small nuclear RNA gene. It is not a protein-coding gene, not a receptor or any molecule of pharmacological interest, does not interact with drugs, and has no clinical or biomarker relevance. Its presence in the genome reflects evolutionary gene duplication and pseudogenization events.
- Other names
- RNU2-13PRNA, U2 small nuclear 13, pseudogene
02
Mechanism of action
None
03
Biological functions
No known biological function (as a pseudogene); functional U2 snRNA is involved in pre-mRNA splicing, but this copy is non-functional
04
Disease associations
None known (no disease relevance documented; pseudogenes generally do not contribute to disease unless by rare regulatory mechanisms)
Beyond the preview
Go deeper on RNA, U2 small nuclear 13, pseudogene (RNU2-13P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U2 small nuclear 13, pseudogene (RNU2-13P).